NEW YORK (GenomeWeb) – Biotechnology company Ignyta announced today that it has received an investigational device exemption (IDE) from the US Food and Drug Administration for its RNA-based companion diagnostic Trailblaze Pharos.
...and receive Daily News bulletins.
Already have an account?Login Now.
Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.
Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.
Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.
In Science this week: gut microbiome influences liver cancer growth, spread; and more.
This webinar will present data from the FLAURA trial and show the clinical utility of liquid biopsy in identifying non-small-cell lung cancer (NSCLC) patients who may benefit from targeted TKI therapies.